Factors related to post-treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapy.
about
Outcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factorsDurability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or TenofovirHepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.When to stop nucleos(t)ide analogues treatment for chronic hepatitis B? Durability of antiviral response.Combining age and HBsAg level predicts post-treatment durability of nucleos(t)ide analogue-induced HBeAg seroconversion.Clinical outcomes and predictors for relapse after cessation of oral antiviral treatment in chronic hepatitis B patients.Extended lamivudine consolidation therapy in hepatitis B e antigen-positive chronic hepatitis B patients improves sustained hepatitis B e antigen seroconversion.To stop or not to stop: the quest for long-term viral suppression.Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy.The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion.
P2860
Q27020938-AF991B15-860B-42F0-93ED-06035A84205FQ36716653-76C94616-461D-4B8D-A5DC-FDCEA23A6D9BQ37762545-25F82280-F10D-4D88-B3D3-66874620A3B5Q38223364-CAA78322-BAFB-4C3E-9824-708439C3F44BQ39069309-D6D1B152-35E6-4BD3-97D6-4C505C8FEF87Q40189344-E4EC3CB0-0E00-4A4F-96BA-6F637A5C7B91Q43210150-06B11C3A-84AE-4E7D-8FA6-634ECD9269E6Q44136161-DF314B00-485B-42B1-8D8D-6D2A7811BC61Q45403524-22196BC1-8299-4CBC-BDF2-2AB1ED27D74EQ46004779-FDEFAB05-D608-4AD4-88F0-11DFCCF88704
P2860
Factors related to post-treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Factors related to post-treatm ...... BeAg after lamivudine therapy.
@en
Factors related to post-treatm ...... BeAg after lamivudine therapy.
@nl
type
label
Factors related to post-treatm ...... BeAg after lamivudine therapy.
@en
Factors related to post-treatm ...... BeAg after lamivudine therapy.
@nl
prefLabel
Factors related to post-treatm ...... BeAg after lamivudine therapy.
@en
Factors related to post-treatm ...... BeAg after lamivudine therapy.
@nl
P2093
P2860
P1476
Factors related to post-treatm ...... HBeAg after lamivudine therapy
@en
P2093
Chang Hong Lee
Hyung Joon Yim
Jae Seon Kim
Jin Yong Kim
Jong Eun Yeon
Jong Jae Park
Ju Hyun Kim
Kwan Soo Byun
Oh Sang Kwon
Yun Jung Chang
P2860
P304
P356
10.1111/J.1440-1746.2005.03952.X
P577
2005-12-01T00:00:00Z